Anika Therapeutics
ANIK
ANIK
165 hedge funds and large institutions have $574M invested in Anika Therapeutics in 2019 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 55 increasing their positions, 50 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
165
Holders Change
+8
Holders Change %
+5.1%
% of All Funds
3.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
55
Reduced
50
Closed
21
Calls
$4.6M
Puts
$832K
Net Calls
+$3.77M
Net Calls Change
+$8.76M
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$14.5M |
| 2 |
Goldman Sachs
New York
|
+$6.12M |
| 3 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
+$4.37M |
| 4 |
D.E. Shaw & Co
New York
|
+$4.12M |
| 5 |
Natixis Advisors
Boston,
Massachusetts
|
+$4.11M |
Top Sellers
| 1 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$6.22M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$3.69M |
| 3 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$3.52M |
| 4 |
JG
Jefferies Group
New York
|
-$3.48M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.07M |
